Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2006-05-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0602566103PMID 16717196PMCID PMC1464378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rescue of influenza A virus from recombinant DNA.

  2007cited by this paper
• Hunt for Birthplace of Meteorites Yields New View of Earth's Origins

  2006cited by this paper
• Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control.

  2006cited by this paper
• H5N1 Moves Into Africa, European Union, Deepening Global Crisis

  2006cited by this paper
• Emerging and Re-Emerging Infectious Diseases: Influenza as a Prototype of the Host-Pathogen Balancing Act

  2006cited by this paper
• Live Bivalent Vaccine for Parainfluenza and Influenza Virus Infections

  2005cited by this paper
• Influenza: lessons from past pandemics, warnings from current incidents

  2005cited by this paper
• Avian flu: H5N1 virus outbreak in migratory waterfowl

  2005cited by this paper
• Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.

  2004cited by this paper
• Role of Transmembrane Domain and Cytoplasmic Tail Amino Acid Sequences of Influenza A Virus Neuraminidase in Raft Association and Virus Budding

  2004cited by this paper
• Human Illness from Avian Influenza H7N3, British Columbia

  2004cited by this paper
• Influenza: Emergence and Control

  2004cited by this paper
• Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

  2004cited by this paper
• Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission

  2004cited by this paper
• Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: non-virulent cleavage site mutants revert to virulence after one passage in chicken brain.

  2003cited by this paper
• Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle Disease

  2003cited by this paper
• Chimeric Influenza A Viruses with a Functional Influenza B Virus Neuraminidase or Hemagglutinin

  2003cited by this paper
• A summary of taxonomic changes recently approved by ICTV

  2002cited by this paper
• Recombinant Newcastle Disease Virus as a Vaccine Vector

  2001cited by this paper
• Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation.

  2000cited by this paper
• Generation of recombinant lentogenic Newcastle disease virus from cDNA.

  1999cited by this paper
• Rescue of Newcastle Disease Virus from Cloned cDNA: Evidence that Cleavability of the Fusion Protein Is a Major Determinant for Virulence

  1999cited by this paper
• Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses.

  1997cited by this paper
• A plasmid-based reverse genetics system for influenza A virus

  1996cited by this paper
• Evolution and ecology of influenza A viruses

  1992cited by this paper
• Pandemic influenza: a zoonosis?

  1992cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector.

  1991cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector

  1991cited by this paper
• A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV.

  1990cited by this paper
• Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase gene.

  1990cited by this paper
• Differences in RNA patterns of influenza A viruses

  1976cited by this paper

• RNA replicon vaccination confers long-lasting protection against H5N1 avian influenza in 23 zoo bird species

  2025cites this paper
• Immunogenetic insights into matching bivalent inactivated Payavax G79® for sustainable poultry vaccination against NDV-GVII and H9N2

  2025cites this paper
• Integrative multi-omics analysis in vivo identifies influenza virus host factors

  2025cites this paper
• Immunopotential of the Combine Vaccine against Fowl Cholera and Avian Influenza Virus in Poultry

  2025cites this paper
• Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine

  2025cites this paper
• The Alarming Situation of Highly Pathogenic Avian Influenza Viruses in 2019–2023

  2024cites this paper
• Negative-Strand RNA Virus-Vectored Vaccines.

  2024cites this paper
• Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses

  2024cites this paper
• Poultry Vaccine Technology Platforms.

  2023cites this paper
• The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus

  2023cites this paper
• Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization.

  2023cites this paper
• Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

  2023cites this paper
• Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets

  2023cites this paper
• Development of in Ovo-Compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase Acidic X Frameshifting sites.

  2023cites this paper
• Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China

  2022cites this paper
• Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken

  2022cites this paper
• Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability.

  2022cites this paper
• AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma

  2022cites this paper
• Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy

  2022cites this paper
• Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human

  2022cites this paper
• Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models

  2022cites this paper
• Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use

  2022influential citation
• The Development of Classical Swine Fever Marker Vaccines in Recent Years

  2022cites this paper
• Assessment of the virulence for chickens of Newcastle Disease virus with an engineered multi-basic cleavage site in the fusion protein and disrupted V protein gene.

  2022cites this paper
• Novel Recombinant Newcastle Disease Virus-Based In Ovo Vaccines Bypass Maternal Immunity to Provide Full Protection from Early Virulent Challenge

  2021cites this paper
• Insights into veterinary vaccinology: Bygone and Future

  2021influential citation
• Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease

  2021cites this paper
• A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

  2021cites this paper
• A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters

  2021cites this paper
• Viral Vectors in Veterinary Vaccine Development: A Textbook

  2021cites this paper
• Newcastle Disease Virus

  2021cites this paper
• The Expression of Hemagglutinin by a Recombinant Newcastle Disease Virus Causes Structural Changes and Alters Innate Immune Sensing

  2021cites this paper
• Avian Paramyxoviruses as Vectors for Vaccine Development.

  2021cites this paper
• Reverse Genetics and Its Usage in the Development of Vaccine Against Poultry Diseases.

  2021cites this paper
• Chicken ISG12(2) attenuates Newcastle disease virus and enhances the efficiency of Newcastle disease vaccine via activating immune pathways.

  2021cites this paper
• Development and pre-clinical evaluation of Newcastle disease virus-vectored SARS-CoV-2 intranasal vaccine candidate

  2021cites this paper
• Biodata and biotechnology: Opportunity and challenges for Australia

  2020cites this paper
• Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates.

  2020cites this paper
• Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

  2020cites this paper
• Current status of virus-vectored vaccines against pathogens that affect poultry.

  2020cites this paper
• Protection of Chickens with Maternal Immunity Against Avian Influenza Virus (AIV) by Vaccination with a Novel Recombinant Newcastle Disease Virus Vector

  2020cites this paper
• The expression of hemagglutinin by a recombinant Newcastle disease virus causes structural changes and alters innate immune sensing

  2020cites this paper
• Structural and functional impact of the H5 hemagglutinin expression into a NDV vector vaccine backbone

  2020cites this paper
• Viruses and the Evolution of Viral Vectors

  2020cites this paper
• Paramyxoviruses as Vaccine Vectors

  2020cites this paper
• Advances and applications of vectored vaccines in animal diseases

  2020cites this paper
• Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion

  2020cites this paper
• Potential of plasmid only based reverse genetics of rotavirus for the development of next-generation vaccines.

  2020cites this paper
• Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

  2020cites this paper
• Structural and functional impact of the H 5 hemagglutinin expression into a NDV vector vaccine 1 backbone 2 3

  2020cites this paper
• Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells

  2020cites this paper
• Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology

  2020cites this paper
• Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels.

  2020cites this paper
• Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference

  2020influential citation
• Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells

  2019cites this paper
• A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.

  2019cites this paper
• Recombinant influenza A viruses as vaccine vectors

  2019influential citation
• Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines

  2019influential citation
• Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens

  2019cites this paper
• Newcastle Disease Virus

  2019cites this paper
• Newcastle disease virus vectors expressing consensus sequence of the H7 HA protein protect broiler chickens and turkeys against highly pathogenic H7N8 virus.

  2019cites this paper
• Evaluation of surface glycoproteins of classical swine fever virus as immunogens and reagents for serological diagnosis of infections in pigs: a recombinant Newcastle disease virus approach

  2019cites this paper
• Co-expression of the Hemagglutinin and Neuraminidase by Heterologous Newcastle Disease Virus Vectors Protected Chickens against H5 Clade 2.3.4.4 HPAI Viruses

  2018cites this paper
• Reverse Genetics for Newcastle Disease Virus as a Vaccine Vector

  2018cites this paper
• Recent advances in viral vectors in veterinary vaccinology.

  2018cites this paper
• Rekombinant DNA Teknolojisinin Veteriner Aşılarda Kullanımı

  2018cites this paper
• Development of a vaccine against Newcastle Disease and antimicrobials for Salmonella serovars

  2018cites this paper
• METHODS FOR IMMUNIZING AGAINST AVIAN INFECTIOUS BRONCHITIS VIRUS

  2017cites this paper
• Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.

  2017cites this paper
• Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines

  2017cites this paper
• Recombinant viral-vectored vaccines for the control of avian influenza in poultry.

  2017cites this paper
• Protection by Classical and Vectored Vaccines against Endemic Velogenic Newcastle Disease in broiler Farms and Evaluation of a Developed Autogenous Vaccine against Predominant Genotype VI

  2017cites this paper
• The role of vaccination in risk mitigation and control of Newcastle disease in poultry.

  2017cites this paper
• Recombinant Avian Paramyxovirus Serotypes 2, 6, and 10 as Vaccine Vectors for Highly Pathogenic Avian Influenza in Chickens with Antibodies Against Newcastle Disease Virus

  2017cites this paper
• Vaccines against avian influenza in poultry.

  2017cites this paper
• Production of recombinant Erns protein of classical swine fever virus and assessment of its enzymatic activity: A recombinant Newcastle disease virus-based approach

  2017cites this paper
• Role of water chemistry and stabilizers on the Vero-cells-based infectivity of Newcastle disease virus live vaccine

  2017cites this paper
• Chimeric rabies glycoprotein with a transmembrane domain and cytoplasmic tail from Newcastle disease virus fusion protein incorporates into the Newcastle disease virion at reduced levels

  2017cites this paper
• Two-plasmid system to increase the rescue efficiency of paramyxoviruses by reverse genetics: The example of rescuing Newcastle Disease Virus.

  2017cites this paper
• Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design

  2017cites this paper
• A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.

  2017cites this paper
• Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.

  2017cites this paper
• Vaccines and vaccination for avian influenza in poultry.

  2016cites this paper
• Improvement of immune responses to influenza vaccine (H5N1) by sulfated yeast beta-glucan.

  2016cites this paper
• Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector

  2016cites this paper
• Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.

  2016cites this paper
• Newcastle disease vaccines—A solved problem or a continuous challenge?

  2016cites this paper
• Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines

  2016cites this paper
• P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression.

  2015cites this paper
• A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response

  2015cites this paper
• The reoccurrence of H5N1 outbreaks necessitates the development of safe and effective influenza vaccine technologies for the prevention and control of avian influenza in Sub-Saharan Africa

  2015cites this paper
• Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses

  2015cites this paper
• Design of alternative live attenuated influenza virus vaccines.

  2015cites this paper
• NAHEMS Guidelines: Vaccination for Contagious Diseases, Appendix C: Vaccination for High Pathogenicity Avian Influenza

  2015cites this paper
• RNA-based viral vectors

  2015cites this paper
• Improved immune responses to a bivalent vaccine of Newcastle disease and avian influenza in chickens by ginseng stem-leaf saponins.

  2015cites this paper
• Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses

  2015cites this paper
• Development of a Newcastle disease virus vector expressing a foreign gene through an internal ribosomal entry site provides direct proof for a sequential transcription mechanism.

  2015cites this paper
• Vaccines against influenza A viruses in poultry and swine: Status and future developments.

  2015cites this paper
• Generation of Influenza Virus from Avian Cells Infected by Salmonella Carrying the Viral Genome

  2015cites this paper